Medical Forum / Diseases and Disorders / AIDS / February 2005
results of a new survey
|
|
Thread rating:  |
Death - 17 Feb 2005 01:15 GMT FLEMINGTON, N.J.--(BUSINESS WIRE)--Feb. 16, 2005--
Results of a new national survey of 864 physicians and 1,339 members of the general public revealed that a significant majority of both groups believe that mandatory, federally funded HIV testing would improve the overall health of the U.S. population.
The national e-survey was conducted by HCD Research during February 12 -14, as part of its continuing investigation of the social, political and economic issues confronting the U.S. health care system. The margin of error in the survey was plus or minus 3% at a 95% confidence level.
The survey revealed that among the general public:
-- 63% of Americans believe that mandatory, federally funded HIV testing would improve the overall health of the U.S. population
-- 60% indicated that the associated health care benefits of mandatory, federally funded HIV testing outweigh the social implications
-- 40% indicated that the social implications of mandatory, federally funded HIV testing outweigh the associated health care benefits
The most frequently cited social concerns of those representing the general public who were not in favor of mandatory testing were:
Difficulty obtaining life insurance 76%
Job/employment issues 71%
The least frequently reported social concerns were:
The cost of testing is too high for public funding 52%
Difficulty in marriage and other social relations 51%
Inadequate access to medical and psychological counseling 46%
Among the sample of physicians:
-- 64% believe that mandatory, federally funded HIV testing would improve the overall health of the U.S. population
-- 59% reported that the associated health care benefits of mandatory, federally funded HIV testing outweigh the social implications
-- 41% indicated that the social implications of mandatory, federally funded HIV testing outweigh the associated health care benefits
The most frequently cited social concerns by physicians who were not in favor of mandatory testing were:
Difficulty obtaining life insurance 84%
Job/employment issues 77%
The least frequently reported social concerns were:
Difficulty in marriage and other social relations 48%
Inadequate access to medical and psychological counseling 44%
The cost of testing is too high for public funding 34%
"Physicians are a distinct group who share similar education, income and status in society, and it is intriguing that their views reflect those of the general public on serious and evolving health care issues such as this one," noted Glenn Kessler, Co-Founder and Managing Partner, HCD Research.
According to a recent study in the New England Journal of Medicine, health experts recommend that virtually all Americans be screened routinely for the HIV AIDS virus, much as they are for cancer and other conditions. In addition, the report cited recent federally funded studies which determined that the cost of routinely testing and treating nearly all adults would be outweighed by a reduction in new infections and the opportunity to start patients on antiviral medications early in the disease progression.
HCD Research is a marketing and communications research company headquartered in Flemington, NJ. The company's services include traditional and web-based marketing and communications research. HCD Research also developed readmylipz.com, a political ad testing web site for the 2004 Presidential campaign. For additional information on HCD Research, access the company's web site at www.hcdi.net or call HCD Research at (908) 788-9393.
For more information or to schedule an interview with Glenn Kessler, Co-Founder and Managing Partner, HCD Research, please contact Vince McGourty, M&M Communications, Inc., at 908-638-5555 or vinmcg@earthlink.net.
Contacts
M&M Communications, Inc. Vince McGourty, 908-638-5555 vinmcg@earthlink.net or HCD Research Glenn Kessler, 908-788-9393 grkessler@hcdi.net
PaulKing - 17 Feb 2005 05:28 GMT HCD Research
Marketing company for the drugs and test companies.
Trip Trepagnier, Vice President, Marketing Research Services
He also was director of centralized marketing and headed U.S. point-of-care marketing for Bayer Diagnostics, and held sales and marketing management positions of increasing scope and responsibility with DuPont Diagnostics.
Glenn Kessler, Managing Partner
Prior to founding HCD Research, Kessler held sales and marketing positions with Roche Diagnostic Systems, Inc. and Ortho Diagnostics Systems, a Johnson & Johnson company. He served as director of national accounts and was a member of the Roche Diagnostic Operating Committee.
Ina Noble, Director, Marketing Research Services
Noble has held sales and marketing positions with SMG Marketing Group, IMS, Dentsply International, Becton Dickinson and Company, EM Diagnostics, Inc. and ER Squibb and Sons, Inc.
Arthur J. Kover, Ph.D. Senior Consultant, Adversting Research Services
Dr. Kover is a leader in the design and execution of advertising research programs. During the 90’s, he was the Chairman of the Marketing Department at Fordham University’s Graduate School of Business. Prior to entering academia, Dr. Kover spent 20 years directing research initiatives at some of the world’s largest advertising agencies including, Kenyon & Eckhardt (now Bozell), Cunningham & Walsh and J. Walter Thompson.
PaulKing - 17 Feb 2005 10:18 GMT Funny how the senior personel of this market research company worked for just about every manufacturer of multi million dollar AIDS and Hep C diagnostic machines.
Who thinks their survey was without bias?
RDI is a distributor of fine immunochemical products including pure Janssen drugs for in vitro research (anti-fungals, anti-psychotics, anti-histaminics, anti-neuroleptics and more..) , monoclonal antibodies against items as CD clustered immunoglobulins, anti-growth factors, receptors, proteins, tumor markers, toxins, viruses, cytokeratins, cytoskeletal proteins, and ion transport proteins (NA K & Ca ATPase etc) , high purity immunochemicals as cytokines, growth factors, and chemokines, Gold conjugates EM/LM/Bioassay use, detection systems as our POLY-HRP Product line and reagents for sensitive ELISA and histochemical development, Cytochrome P450 enzymes and antibodies for drug research, new Elisa kits for Biogenic amines (histamine, adrenaline, metanephrine, serotonin and more). , Other Kits for Cytokines, IgG Subclass, Steroid Hormones , Bioprocess Contaminants (see master kit list) .... & Pure Antigens for immunoassay development and in vitro research use. CLICK HERE to see our list of pure/USP grade drug/metabolites/analytical standards
_______
Ortho Diagnostics Systems
The right assay at the right time-ready for automation
Only Ortho has all the assays required today for donor screening. Ortho has an unparalleled track record of being first to market with assays and systems technology. And we'll continue to provide new tests and technologies as needed to continue to ensure a safe blood supply.
Screening Assays
HCV Version 3.0 ELISA HIV-1 p24 Antigen ELISA HIV-1/HIV-2 Peptide EIA HTLV-I/II ELISA HBsAg System 3.0 HBc ELISA System
Confirmatory Assays
Chiron™ RIBA™ HCV 3.0 SIA HBsAg 3.0 ELISA Confirmatory Test HIV-1 p24 Antigen Neutralization Kit
______________
Bayer Diagnostics
Immunodiagnostics ACS:180® SE Automated Chemiluminescence System
ADVIA Centaur® Immunoassay System
Bayer Immuno 1® Immunoassay Analyzer
______
Roche Diagnostics is the premier diagnostics company, with unrivalled breadth and depth of technology, broad product and service offerings, and a strong global presence. Our products and services meet the expectations of people working in large and small medical laboratories, physicians' offices, pharmacies, research labs and industry as well as the needs of patients requiring assistance with self-monitoring.
Main products: - AIDS and Hep C machines
|
|
|